Medical Cost Trajectories and Onsets of Cancer and NonCancer Diseases in US Elderly Population

Time trajectories of medical costs-associated with onset of twelve aging-related cancer and chronic noncancer diseases were analyzed using the National Long-Term Care Survey data linked to Medicare Service Use files. A special procedure for selecting individuals with onset of each disease was developed and used for identification of the date at disease onset. Medical cost trajectories were found to be represented by a parametric model with four easily interpretable parameters reflecting: (i) prediagnosis cost (associated with initial comorbidity), (ii) cost of the disease onset, (iii) population recovery representing reduction of the medical expenses associated with a disease since diagnosis was made, and (iv) acquired comorbidity representing the difference between post- and pre diagnosis medical cost levels. These parameters were evaluated for the entire US population as well as for the subpopulation conditional on age, disability and comorbidity states, and survival (2.5 years after the date of onset). The developed approach results in a family of new forecasting models with covariates.

[1]  K G Manton,et al.  Projecting the future size and health status of the U.S. elderly population. , 1992, International journal of forecasting.

[2]  Paul G Shekelle,et al.  Consequences of health trends and medical innovation for the future elderly. , 2005, Health affairs.

[3]  H. Temkin-Greener,et al.  Medicare capitation model, functional status, and multiple comorbidities: model accuracy. , 2008, The American journal of managed care.

[4]  J. Lubitz,et al.  Trends in Medicare payments in the last year of life. , 1993, The New England journal of medicine.

[5]  H. Quan,et al.  Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.

[6]  Purushottam W. Laud,et al.  An Algorithm for the Use of Medicare Claims Data to Identify Women with Incident Breast Cancer , 2004 .

[7]  Lisa I. Iezzoni,et al.  Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model , 2004, Health care financing review.

[8]  Paul P. Lee,et al.  Estimates of incidence rates with longitudinal claims data. , 2003, Archives of ophthalmology.

[9]  K. Manton,et al.  Change in chronic disability from 1982 to 2004/2005 as measured by long-term changes in function and health in the U.S. elderly population , 2006, Proceedings of the National Academy of Sciences.

[10]  W. Lawrence,et al.  Comparison of Approaches for Estimating Prevalence Costs of Care for Cancer Patients: What Is the Impact of Data Source? , 2009, Medical Care.

[11]  Ruta Bajorunaite,et al.  An algorithm for the use of Medicare claims data to identify women with incident breast cancer. , 2006, Health services research.

[12]  L. Bouter,et al.  How to measure comorbidity. a critical review of available methods. , 2003, Journal of clinical epidemiology.

[13]  Dana P. Goldman,et al.  Health Status and Medical Treatment of the Future Elderly: Final Report , 1995 .

[14]  K. Manton,et al.  Life Tables with Covariates: Dynamic Model for Nonlinear Analysis of Longitudinal Data , 2005 .

[15]  T. Miller Increasing longevity and medicare expenditures , 2001, Demography.

[16]  Baoping Shang,et al.  The Value of Elderly Disease Prevention , 2006, Forum for health economics & policy.

[17]  Dove Hg,et al.  Episode Treatment Groups (ETGs): a patient classification system for measuring outcomes performance by episode of illness. , 2000 .

[18]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[19]  Angela Mariotto,et al.  Cost of care for elderly cancer patients in the United States. , 2008, Journal of the National Cancer Institute.

[20]  S. Ramsey,et al.  Evidence, economics, and emphysema: Medicare's long journey with lung volume reduction surgery. , 2005, Health affairs.

[21]  Anatoliy I. Yashin,et al.  Circulatory Diseases and Aging , 2008 .

[22]  S. Z. Nagi An epidemiology of disability among adults in the United States. , 1976, The Milbank Memorial Fund quarterly. Health and society.

[23]  Dana P. Goldman,et al.  Health Status and Medical Treatment of the Future Elderly , 2004 .

[24]  G. H. Moore,et al.  Consumer Price Index , 1993 .

[25]  J. Lubitz Health, technology, and medical care spending. , 2005, Health affairs.

[26]  K. Manton,et al.  Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Manton,et al.  Age Patterns of Disease Incidences in the U . S . Elderly : Population-Based Analysis , 2006 .

[28]  Federico Girosi,et al.  The benefits of risk factor prevention in Americans aged 51 years and older. , 2009, American journal of public health.

[29]  E. Lander,et al.  Effects of Medical Research on Health Care and the Economy , 1999, Science.